TGTX SHAREHOLDER ALERT: Jakubowitz Law Reminds TG Therapeutics Shareholders of a Lead Plaintiff Deadline of September 16, 2022

NEW YORK, Aug. 5, 2022 /PRNewswire/ — Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of TG Therapeutics, Inc. (NASDAQ: TGTX). To receive updates on the lawsuit, fill out the form:…